Heart Test Laboratories
HSCS
22 hedge funds and large institutions have $181K invested in Heart Test Laboratories in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
16% more funds holding
Funds holding: 19 → 22 (+3)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
11% less capital invested
Capital invested by funds: $203K → $181K (-$22.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$21.6K |
| 2 |
HF
HRT Financial
New York
|
+$16K |
| 3 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
+$13.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$44K |
| 2 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$10.3K |
| 3 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$1.86K |
| 4 |
ACM
AlphaStar Capital Management
Cornelius,
North Carolina
|
-$78 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$17 |
HSCS Hedge Fund Activity: Q1 2024 in Review
22 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q1 2024, worth a combined $181K — down 11% from $203K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HSCS positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $21.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $44K sold.
- 22 institutional investors held Heart Test Laboratories (HSCS) as of Q1 2024, up from 19 in Q4 2023.
- Funds reported $181K of Heart Test Laboratories stock for Q1 2024, down 11% quarter-over-quarter.
- 6 funds opened new Heart Test Laboratories positions in Q1 2024 and 3 closed out, a net change of +3 holders.
- The largest Heart Test Laboratories buyer in Q1 2024 was Northern Trust, an estimated $21.6K added.
- The largest Heart Test Laboratories seller in Q1 2024 was Virtu Financial, an estimated $44K sold.
Based on aggregated 13F filings for Q1 2024.